Project Overview

In the rapidly evolving biotechnology sector of 2025, the demand for high-purity vaccine production facilities has surged. This case study focuses on the design and construction of a state-of-the-art ISO 5 cleanroom tailored for a leading pharmaceutical company specializing in mRNA vaccine production. The facility was required to meet stringent Good Manufacturing Practice (GMP) standards while ensuring maximum operational efficiency and contamination control.

Client Challenges

The client faced several critical challenges during the planning phase. Firstly, maintaining ISO 5 classification (Class 100) in a high-traffic production environment required sophisticated airflow dynamics. Secondly, temperature and humidity control needed to be precise within ±0.5°C and ±2% RH to protect sensitive biological materials. Lastly, the facility had to be constructed within a tight timeline of six months to meet regulatory approval deadlines for upcoming clinical trials.

Design Solution

Our engineering team developed a comprehensive design centered around a unidirectional airflow system. The cleanroom utilized a full ceiling of High-Efficiency Particulate Air (HEPA) filters with a filtration efficiency of 99.99% at 0.3 microns. The HVAC system was designed with redundancy to ensure continuous operation even during maintenance. We implemented a modular wall system made of galvanized steel with powder coating to prevent particle shedding and facilitate easy cleaning.

Construction Details

The construction phase involved rigorous sealing of all joints to prevent air leakage. Epoxy resin flooring was installed to provide a seamless, chemical-resistant surface. All electrical conduits were embedded within the wall panels to minimize dust accumulation points. Special attention was paid to the pass-through chambers, which were equipped with interlocking doors and UV sterilization to maintain pressure differentials between zones.

Validation and Testing

Upon completion, the facility underwent extensive validation protocols. Particle count tests confirmed ISO 5 compliance across all critical zones. Airflow velocity tests ensured uniform distribution without turbulence. Pressure differential monitoring systems were calibrated to alert staff immediately of any deviations. Microbial settlement plates were used to verify biological cleanliness levels over a 72-hour period.

Outcome and Benefits

The completed cleanroom exceeded client expectations. Production yield increased by 15% due to reduced contamination events. Energy consumption was optimized through variable frequency drives on fan filter units, resulting in a 20% reduction in operational costs. The facility successfully passed regulatory inspections within the first month of operation, enabling the client to accelerate their vaccine rollout schedule significantly.